The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2019 | CAR T-cell therapy: how caregivers are affected
Surbhi Sidana
• 3 Jun 2019
Here, Surbhi Sidana, MD, of the Mayo Clinic, Rochester, MN discusses an important aspect of CAR T-cell therapy; how the QoL of caregivers are affected and why this is crucial to address going forward. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.
